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ABSTRACT
Conclusions The results provide preliminary evidence that corticosteroids were not effective in all
grades of dysfunction and for achieving a rapid remission in the early phase of BP, highlighting the
need to define standard and rigorous criteria to prescribe corticosteroids in these patients. Objectives
The main aim of this study was to investigate whether the use of corticosteroids better associated than
paralleled with neuromuscular training (Cþ FNT) is more effective than facial neuromuscular training
(FNT) applied alone, in terms of recovery degree and facial symmetry during the early phase of Bell’s
palsy (BP). Patients and methods A prospective single-blinded study involved 73 patients: the Cþ FNT
group (n¼ 42; median age ¼ 37.5 years) and FNT group (n¼ 31; median age ¼ 49.0 years). Patients
were assessed before and 6 weeks after treatment by House-Brackmann (HB-FGS) and Sunnybrook
Facial Grading System (SB-FGS). Results Recovery degree and facial symmetry improved significantly in
both groups (p< 0.001), without differences between groups (p> 0.05). However, the Cþ FNT group
displayed better outcomes for cheek (p¼ 0.004) and mouth (p¼ 0.022) resting symmetry at SB-FGS,
instead of compared to the FNT group. The corticosteroids had no significant effect on all recovery
degrees (p¼ 0.992) and rapid remission (p¼ 0.952). Multiple linear regression analysis showed that the
type of intervention was not a significant predictor for recovery degree (p¼ 0.917).
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Introduction
Bell’s palsy (BP) is defined as an acute unilateral paralysis or
paresis of the facial nerve without any associated disorders
[1]. Incomplete recovery from facial nerve damage has sig-
nificant social and psychological consequences [2]. Although
the prognosis of BP is generally good, with a high rate of
recovery, 29% of patients were reported as having sequels
[1]. Moreover, patients with facial paralyses and absence of
recovery within 3 weeks may experience poor outcomes [1].
Pathologically HSV-1 (re)activation results in an inflam-
mation of the seventh facial nerve, which leads to compres-
sion within the bony canal fallopian and nerve
demyelination [3]. Based on this, the American Academy of
Neurology [4] established that powerful anti-inflammatory
agents, such as oral corticosteroids, are effective in improving
facial function outcomes in BP. Furthermore, Sullivan et al.
[5] reported a significant improvement of facial nerve func-
tion in patients treated with prednisolone within 72 h of
onset. On the other hand, systematic reviews have concluded
that the recommendation for optimal physical therapy of BP
is difficult due to the limited number and low quality of tri-
als and the heterogeneity of results [6–8].
The recent Canadian Guidelines recommend the use of
corticosteroids for all patients with BP [9]. Moreover, Indian
Guidelines include physical therapy and corticosteroids for
targeting the speed recovery [10]. Thus, there are no data
regarding the effects of corticosteroids treatment vs facial
neuromuscular training only, in the early phase of BP.
In this study, the main goal was to investigate whether
the use of corticosteroids with neuromuscular training is
more effective than neuromuscular training alone, in terms
of recovery degree and facial symmetry during the early
phase of BP. Four main hypotheses were tested: (1) cortico-
steroids treatment influences positively the recovery degree
and facial symmetry; (2) patients with a high degree of sever-
ity have more benefits with the corticosteroids; (3) recovery
is faster with the corticosteroids; and (4) predictors, such as
age, sex, baseline HB-FGS, and intervention type, influence
the degree of recovery.
Methods
Subjects and experimental design
The study was a prospective single-blinded study performed
in patients with peripheral facial paralysis, screened from
January 2009 to May 2013. The first clinical visit included
examinations by a clinical physician, an otolaryngologist, and
a physiatrist, according to the routine protocol of hospital-
Portugal. In the Emergency department, all outpatients
were referred to Physical Medicine and Rehabilitation by
the clinical physician. The protocol was approved by the
hospital ethics committee, and written informed consent
was obtained from all studied patients. Baseline sample
was 123 patients with peripheral facial paralysis, diagnosed
by a physiatrist. The eligibility criteria for this study
included: patients with unilateral BP, both gender, aged 18
years and older, onset of oral corticosteroids treatment
within 72 h after BP onset, and facial neuromuscular train-
ing treatment within 10 days after BP onset. Patients were
excluded if they had recurrent facial nerve palsy, a central
nervous system disease, traumatic facial nerve injury, meta-
bolic, infective, cancer, psychiatric condition, neuropathy or
neuromuscular disease, antiviral treatment therapy, cortico-
steroids treatment for others diseases, and the inability to
speak or read Portuguese language.
BP was diagnosed when no other cause was identified
through medical history and physical examination. In case
of a diagnostic disagreement, radiology and laboratory test-
ing were performed. A questionnaire was applied to all
patients, which included demographic data, side of palsy,
symptoms, first consultation, and medical and personal
history. After the diagnosis of BP, 73 patients were divided
into two treatment groups: the Corticosteroids plus Facial
Neuromuscular Training (Cþ FNT) group or the Facial
Neuromuscular Training (FNT) group. The prescription
criteria for corticosteroids administration were unknown
and without any apparent uniformity among the physi-
cians, showing that all patients take corticosteroids inde-
pendently of the level of severity of PB. Blinding to
treatment allocation of participants and physical therapists
was not possible due to the nature of the interventions.
However, clinical physicians and investigators were blind
to the allocated intervention.
Intervention
The Cþ FNT group includes patients taking oral prednisol-
one, within 72 h of BP onset, at a dose of 1mg/kg per day
(maximum 60mg/day) for 5 days, then tapered over 5 days
(10mg/day). FNT was started within 10 days in all patients,
no difference was shown for the timing of the start of the
intervention between groups (4.986 2.38 and 5.296 2.3,
p¼ 0.775 for Cþ FNT and FNT, respectively). Both groups
were treated with FNT individually by five trained physical
therapists in accordance to the facial neuromuscular training
principles [11]. Each patient was treated in the outpatient
hospital, 5 days a week, 20min a day, for 6 weeks or until
complete recovery. In the case of complete recovery, FNT
was no longer performed, although assessment continued
until the sixth week.
A standard program of FNT included different muscle
groups supplied by each branch of the facial nerve in both
sides of the face by using a mirror to promote symmetry and
feedback. The FNT was based on principles of strength
training, overload and specificity [12]. Table 1 shows the
detailed description of each training phase.
Outcome measures
Assessment of patients was performed using two the House-
Brackmann facial grading system (HB-FGS) and Sunnybrook
facial grading system (SB-FGS) [13,14]. The HB-FGS consists
of six grades, where grade I represents normal facial function
in all areas, and grade VI represents total paralysis. This scale
was assessing symmetry, synkinesis, stiffness, and mobility of
the face. Complete recovery was defined as the achievement
of HB-FGS grade I [13]. Facial symmetry was measured
using the 13-item SB-FGS. A composite facial symmetry
score is calculated as [(4 symmetry of voluntary movement
score) – (5 resting asymmetry score)þ (1 synkinesis
score)], with 100 points representing normal facial symmetry
[14]. The score for three sections are combined into a com-
posite facial symmetry score by subtracting the resting asym-
metry and synkinesis. In the present study, the synkinesis
component could not be established due to the absence of
synkinesis in the early phase of BP (score 0/none synkinesis).
However, the absence of this component does not change
the sum of final score. Outcome measurements were assessed
at baseline and after 6-weeks of follow-up period.
Data analysis
Categorical variables are presented as absolute and relative
frequencies, while continuous variables are presented as abso-
lute values, using means and standard deviations, or medians
and interquartile ranges for variables with skewed distribu-
tions. Differences between two interventions (i.e. Cþ FNT vs
FNT) in baseline characteristics were tested using v2 test and
Mann-Whitney U-test, as appropriate. HB-FGS and SB-FGS
scores were analyzed by Kruskall-Wallis test to compare dif-
ferences within- and between-groups. The median variation
of recovery degree, i.e. DHB-FGS and DSB-FGS (final value-
initial value), was tested among groups using the Mann-
Whitney test. v2 test analyzed the differences in proportions
of patients between groups (Cþ FNT vs FNT groups) who
experienced full recovery (HB-FGS grade I) as well as after
stratifying patients according to their baseline HB-FGS
grades (slight-to-moderate severity grade II, III, IV; severe
severity grade V, VI). The remission time was assessed every
week by the number of days to reach HB-FGS grade I, which
was analyzed through hazard curves using Log-Rank Test for
differences among groups. Multiple linear regression was per-
formed to test an association between predictor intervention
group and outcome variable of the DHB-FGS, adjusting for
confounding variables (age, sex, and severity baseline of HB-
FGS). p-values less than 0.05 were considered as significant.
Analyses were performed using SPSS, version 22.0.
Results
All demographic and baseline clinical measures were similar
in both groups (p> 0.05) (Table 2).
According to the HB-FGS, the median paresis severity at
baseline was grade 4 for both groups. On the SB-FGS,
median score at baseline was 26 points in the Cþ FNT
group and 30 points in the FNT group (Table 3). As shown
in Table 3, both groups significantly improved all compo-
nents of facial symmetry (within-group p< 0.05). However,
the Cþ FNT group displayed better outcomes for cheek
(p¼ 0.004) and mouth (p¼ 0.022) resting symmetry com-
pared to FNT group (Table 3). Composite facial symmetry
score improved 74 points in the Cþ FNT group compared
to 70 points in the FNT group.
After 6 weeks, the clinical data indicate that both groups
showed significant improvements of recovery degree (DSB-
FGS), without significant differences between groups
(p> 0.05) (Table 4). Both groups increased  2 HB-FGS,
while DSB-FGS median showed 54.50 points to the Cþ FNT
and 47.0 to the FNT group.
No significant effect of both interventions was found
between groups. Similarly, no differences were found after
stratifying patients according to their baseline HB-FGS
grades (II–IV and V–VI). As shown in Table 5, at the end of
the follow-up period, 27 (64.29%) patients in the Cþ FNT
group and 20 (64.52%) in the FNT group experienced full
recovery (p¼ 0.992).
There were no differences in remission time (reaching
HB-FGS grade I) between groups (p¼ 0.952) (Figure 1). The
average remission time was 17.86 days (95%
CI¼ 15.68–20.03) in the Cþ FNT group and 18.43 days
(95% CI¼ 15.23–21.63) in the FNT group.
Considering the recovery degree (DHB-FGS) in all
patients, a multiple linear regression model was performed
adjusted for variables such as age, sex, baseline HB-FGS,
and intervention groups. Age, sex, and baseline HB-
FGS were significant confounding variables (p< 0.004,
p< 0.003, and p< 0.001, respectively). The type of inter-
vention was not a significant predictor of recovery degree
(p¼ 0.917).
After adjusting for age, sex, and baseline HB-FGS, the
type of intervention was not a significant predictor of recov-
ery degree (DHB-FGS; p¼ 0.917) (Table 6).
Discussion
The results of the present study show that oral administra-
tion of corticosteroids does not bring advantageous effects in
terms of recovery degree and facial symmetry in the early
phase of BP. Moreover, we found some heterogeneity in cor-
ticosteroids prescription among physicians, since they were
Table 2. Demographic and clinical data in both groups.
Cþ FNT group
(n¼ 42)
FNT group
(n¼ 31) p-value
Sex, n (%)
Male 19 (45.24) 16 (51.61) 0.593
Female 23 (54.76) 15 (48.39)
Face side, n (%)
Right 20 (47.62) 13 (41.94) 0.632
Left 22 (52.38) 18 (58.06)
Age (years), Median (IQR) 37.5 (26) 49.0 (33) 0.053
Baseline HB-FGS, n (%) 0.944
Grade II 5 (11.90) 3 (9.68)
Grade III 12 (28.57) 9 (29.03)
Grade IV 5 (11.90) 4 (12.90)
Grade V 4 (9.52) 5 (16.13)
Grade VI 16 (38.10) 10 (32.26)
IQR: interquartile range; HB-FGS: House-Brackmann facial grading system; SB-
FGS: Sunnybrook facial grading system; Cþ FNT: corticosteroids plus facial
neuromuscular training group; FNT: facial neuromuscular training group.
Table 1. Facial neuromuscular training components of intervention.
Phase 1 Information All patients were educated on facial muscle physiology, facial functions and changes induced by
paralysis
Content of the standardized education Postural correction information was given for to increase awareness of the head position and its effect
on facial tone
Relaxation training was taught to increase the participant’s awareness of the hyperactivity of the
unaffected face by breathing and relaxation exercises
Tissue mobilization was taught to improve circulation and sensory stimulation by combination of
‘gliding’ and ‘kneading’, in both side of the face and neck during 5–10min
Strategies were instructed to avoid mass facial movements (excessive chewing on the affected
side), eye protection (wear glasses, an eye shield, and ointment), and oral hygiene
Phase 2
Training components and techniques intervention
All patients were treated individually by a trained physical therapist
Standardized training components The basis exercises consisted of seven facial muscles/motion (Frontalis/wrinkling; Corrugator supercili/
wrinkles of forehead; Orbicularis oculi/closure of eyes; Procerus/snarl; Orbicularis oris/whistling;
Risorius/smile; Zigomaticus/laugh) with variations of speed, amplitude, force, repetitions (from
5–20), series (from 1–2) per each facial muscle, selective and co-ordination motion and other
muscles innervated by the facial nerve. Patients were also taught expression exercises (e.g. to open
the eyes wide/surprise, lift the upper lip/disgust, tighten the lips/anger, lips pucker/kiss or laugh/
happy) and facial function (eat, drink, speak)
Techniques intervention Neuromuscular facial training had two different interventions according to the House-Brackmann-Facial
Grading System assessment. Patients who had severe facial asymmetry at rest or flaccid facial
regions, and who were unable to initiate movement on the affected side were given instructions
on small and controlled movement by passive and active assistive exercises. On the other hand,
patients who had mild-to-moderate facial asymmetry at rest and were able to initiate at least slight
movement in any or all regions of the face were given instructions in the isolated movement and
controlled by active assistive and resistive exercises
Homework In addition, when the patients performed correct movements and symmetry of facial expression, they
were instructed to practice a home-based exercise program, 2 times a day, for no more than
10min per day. Adherence to the home exercise was formally registered daily in a standard docu-
ment by patients and it was weekly controlled by physical therapists.
not prescribed to all patients with the same severity level
of BP.
This study showed that, after 6 weeks, both interventions
reduced the degree of BP severity in a similar way. At the
pre-intervention phase, both groups had similar distribution
of facial grades’ severity, which supports the concept that
post-treatment values provided a reliable evaluation of each
treatment efficacy. After interventions there were no signifi-
cant differences between groups for all components of facial
symmetry at rest and voluntary movement, except for two
parameters (resting symmetry component of cheek and
mouth), revealing that corticosteroids only had positive effects
on rest symmetry with droop corner of mouth and increased
nasal labial fold. Our results do not support the present treat-
ment guidelines, which advocate the use of potent anti-inflam-
matory agents, such as oral corticosteroids, for all patients
with BP to decrease recovery time and improve facial nerve
functional recovery [4,9,10]. These guidelines were based on
the assumption that an early administration of corticosteroids
might reduce the nerve’s swelling and subsequent unblocking
of nerve conduction, in the fallopian canal [1]. These results
may suggest that the corticosteroids dose was insufficient to
promote anti-inflammatory effects in the fallopian canal. The
oral administration has a systemic effect, which may have
Table 3. Baseline and after intervention expressed by HB-FGS and SB-FGS components, in both groups.
Scales
Cþ FNT group FNT group
p-valueþBaseline After intervention p-value* Baseline After intervention p-value*
HB-FGS (I to VI grade) 4.00 (3.0–6.0) 1.00 (1.0–3.0) <0.001 4.00 (3.0–6.0) 1.00 (1.0–2.0) <0.001 0.665
Composite facial symmetry score (0–100) 26.00 (5.0–60.8) 100.00 (83.8–100) <0.001 30.00 (10.0–60.0) 100.00 (79.00–100) <0.001 0.794
Eye (0–1) 1.00 (0.0–1.0) 0.00 (0.0–0.0) <0.001 1.00 (0.0–1.0) 0.00 (0.0–1.0) 0.001 1.000
Cheek (0–2) 0.00 (0.0–1.0) 0.00 (0.0–0.0) <0.001 1.00 (0.0–1.0) 0.00 (0.0–0.0) 0.001 0.004
Mouth (0–1) 0.00 (0.0–1.0) 0.00 (0.0–0.0) <0.001 0.00 (0.0–1.0) 0.00 (0.0–0.0) 0.002 0.022
Resting asymmetry score (0–20) 5.00 (0.0–15.0) 0.00 (0.0–0.0) <0.001 10.00 (0.0–15.0) 0.00 (0.0–5.0) <0.001 0.686
Forehead wrinkle (1–5) 2.00 (1.0–3.8) 5.00 (5.0–5.0) <0.001 2.00 (1.0–2.0) 5.00 (5.0–5.0) <0.001 0.399
Gentle eye closure (1–5) 2.00 (1.0–3.0) 5.00 (5.0–5.0) <0.001 2.00 (1.0–2.0) 5.00 (4.0–5.0) <0.001 0.553
Open mouth smile (1–5) 2.00 (1.0–4.0) 5.00 (5.0–5.0) <0.001 2.00 (1.0–2.0) 5.00 (4.0–5.0) <0.001 0.331
Snarl (1–5) 2.00 (1.0–3.0) 5.00 (5.0–5.0) <0.001 2.00 (1.0–2.0) 5.00 (4.0–5.0) <0.001 0.587
Lip pucker (1–5) 2.00 (1.0–3.0) 5.00 (5.0–5.0) <0.001 2.00 (1.0–2.0) 5.00 (4.0–5.0) <0.001 0.498
Symmetry voluntary movement (20–100) 40.00 (20.0–68.0) 100.00 (92.0–100) <0.001 36.00 (20.0–60.0) 100.00 (84.0–100) <0.001 0.528
*Median and interquartile range differences within groups.
þMedian and interquartile range differences between groups.
Cþ FNT: corticosteroids plus facial neuromuscular training; FNT: facial neuromuscular training; SB-FGS: Sunnybrook facial grading system; HB-FGS: House-Brackmann
facial grading system.
Table 4. the D of HB-FGS and D of SB-FGS, after intervention-baseline intra-groups and between groups.
Scales Cþ FNT FNT p-valueþ
HB-FGS (I–VI grade) 2.00 (3.0. to 2.0) 2.00 (3.0 to 2.0) 0.996
Composite facial symmetry score (0–100) 54.50 (28.0 to 77.3) 47.00 (16.0 to 76.0) 0.476
Eye (0–1) 1.00 (1.0 to 0.0) 0.00 (1.0 to 0.0) 0.889
Cheek (0–2) 0.00 (1.0 to 0.0) 1.00 (1.0 to 0.0) 0.761
Mouth (0–1) 0.00 (1.0 to 0.0) 0.00 (1.0 to 0.0) 0.921
Resting asymmetry score (0–20) 5.00 (15 to 0.0) 5.00 (15.0 to 0.0) 0.648
Forehead wrinkle (1–5) 3.00 (1.0 to 3.0) 2.00 (1.0 to 3.0) 0.490
Gentle eye closure (1–5) 2.00 (1.0 to 3.0) 2.00 (1.0 to 3.0) 0.371
Open mouth smile (1–5) 2.00 (1.0 to 3.0) 2.00 (1.0 to 3.0) 0.631
Snarl (1–5) 3.00 (1.0 to 3.0) 2.00 (1.0 to 3.0) 0.575
Lip pucker (1–5) 2.00 (1.3 to 3.0) 2.00 (1.0 to 3.0) 0.532
Symmetry voluntary movement (20–100) 50.00 (28.0 to 66.0) 44.00 (16.0 to 64.0) 0.487
þ Change after intervention-baseline between groups.
Cþ FNT: corticosteroids plus facial neuromuscular training; FNT: facial neuromuscular retraining; HB-FGS: House-Brackmann facial
grading system; SB-FGS: Sunnybrook facial grading system; D: final values–initial values.
Table 5. Patients’ distribution among HB-FGS grades at the beginning and after 6 weeks of intervention.
HB-FGS
Cþ FNT (n¼ 42)
p-value*
FNT (n¼ 31)
p-value* p-valueþBaseline After 6 weeks Baseline After 6 weeks
HB grade I 0 (0%) 27 (64.29%) <0.001 0 (0%) 20 (64.52%) <0.001 0.992
HB grade II–IV 22 (52.38%) 13 (30.95%) <0.001 16 (51.61%) 7 (22.58%) <0.001 0.777
HB grade V/VI 20 (47.62%) 2 (4.76%) <0.001 15 (48.39%) 4 (12.90%) <0.001 0.703
Cþ FNT: corticosteroids plus facial neuromuscular training; FNT: facial neuromuscular training; HB-FGS: House-Brackmann facial grading system.
*intra-group p  0.001.
þbetween groups.
Table 6. Relationship between the independent and predictive variables.
Independent variables
Unstandardized coefficients
Standardized
coefficients
B (95% CI) SE ß p-value
Constant 2.615 (1.352–3.878) 0.633 – <0.001
Intervention groups 0.024 (0.440–0.488) 0.233 0.010 0.917
Age 0.018 (0.030–0.006) 0.006 0.285 0.004
Sex (male) 0.705 (1.154–0.255) 0.225 0.292 0.003
Baseline of HB-FGS 0.393 (0.241–0.545) 0.076 0.480 <0.001
B: Unstandardized Coefficient; ß: Standardized Coefficient; SE: Standard Error;
Independent variables: age, sex, baseline HB-FGS, and intervention groups;
Predictor: D of recovery degree (HB-FGS).
compromised the local effect at the fallopian canal.
Independently of the underlying reasons, our results suggest
that the criteria to prescribe corticosteroids in BP must be
revised. Other variables may influence the impact of cortico-
steroids, including the specific pharmacologic agent (methyl-
prednisolone, prednisolone, deflazacort, or dexamethasone)
and duration (short vs long duration).
The homogeneous distribution of BP severity among the
groups at the beginning of the interventions clearly suggests
the absence of standard criteria to prescribe corticosteroids
by clinical physicians, once there are slight-to-moderate
degrees (HB-FGS/grade II–IV) and severe degrees (HB-FGS/
grade V–VI) of BP with and without corticosteroids therapy.
Fortunately, this absence of uniform criteria allows us to
obtain a great homogeneity in the distribution of BP severity
between groups at the beginning of the experimental proto-
col, demonstrating also that both interventions had similar
effects in all recovery degrees of patients, independently of
severity level at baseline (p¼ 0.992). Unlike our results,
another study showed that drugs therapy (corticosteroids and
valacyclovir) plus facial exercises had significant effect on the
grade (p¼ 0.038) and time (p¼ 0.044) of full recovery in
patients with severe facial palsy (HB-FGS/grade V–VI) [15].
However, differences in the characteristics of the enrolled
patients (HB grade IV and V–VI vs II–IV and V/VI), inter-
vention types and biased variables’ control (drugs
therapyþ FNT and drugs therapy vs Cþ FNT and FNT
only), and length of follow-up (6 months vs 6 weeks) limit a
direct comparison between studies.
Both interventions showed positive results (HB-FGS and
SB-FGS), but the occurrence of spontaneous recovery in the
acute phases of BP may have influenced our results. In fact,
an early study demonstrated that spontaneous recovery of
the facial nerve follows a predictable time course after an
injury, reporting a complete recovery of 85% of patients
within 3 weeks [1]. Peitersen [1] showed that full spontan-
eous recovery may not occur in all patients with facial nerve
paralysis and, for this reason, various therapies [5,11,15]
have been designed to enhance functional recovery and
reduce sequels of BP. Facial exercise is a conservative inter-
vention for this condition and is considered to be an effective
form of treatment [6,11,15], although its effects have been
found to be debatable according to different guidelines
[9,10]. FNT provides specific exercises and strategies based
on individual function, muscle characteristics, and degree of
facial neuromuscular damage (symptoms and clinical signs)
[11]. This approach integrates the fields of therapeutic,
behavioral, and educational science with the goal of restoring
muscular function, and prevents irregular muscular activity,
as much as possible, in order to improve facial functions
(eating, drinking, speaking clearly, and expressing emotions)
[11]. Although there is no compelling evidence about the
effectiveness of FNT intervention, some studies have recog-
nized the efficacy of functional recovery on early stages of
BP [16,17]. Theoretically, manual mechanism stimulation
directly affects the enervated muscles fibers by increasing the
circulation, maintaining membrane properties, and conse-
quently improving the motor response [18].
Finally, our results showed that age, sex, and level of base-
line HB-FGS might be useful to predict the recovery degree,
irrespective of the intervention groups. Similarly to our
results, other studies have also reported that old patients
C+FNT, corticosteroids plus facial neuromuscular retraining; FNT, facial neuromuscular
training; HB-FGS, House-Brackmann facial grading scale
Incomplete recovery d0 d≤30d≤20d≤10
C+FNT group
FNT group
42 (100%) 3 (85.7%) 19 (45.2%) 15 (35.7%)
31 (100%) 27 (87.1%) 14 (41.9%) 11 (35.5%)
Figure 1. Hazard curves for complete recovery, according to intervention group.
have a poor prognosis, which may be due to an age-related
increase in brain cytokine activity that impairs the ability of
cell repair [19]. Our results showed a better prognosis for
females, which might be explained, among others factors, by
the influence of the endocrine environment, once the anti-
inflammatory role with favorable effects of estrogens in
many diseases are well known [20]. Further research is
necessary to clarify the potential effect of gender as a pre-
dictor factor to full recovery of BP.
Study limitations
This study had both strengths and limitations. The strengths
of the study included the rigorous control to reduce bias
through blinded assessment and patient’s selection (homo-
genous population with exclusion of many comorbidity). The
limitations of the study were the lack of a control group to
assess spontaneous recovery, which restricts the analysis of
FNT effectiveness. However, a control group was not
included due to ethical reasons.
Conclusions
Our results provide preliminary evidence that the oral intake
of corticosteroids was not effective in all grades of dysfunc-
tion and remission time at the early phase of BP, highlight-
ing the need to re-analyze the criteria to prescribe
corticosteroids in these patients.
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